Parkinson s DiseaseMI-SeRNCT07860294
Effects of Mental Imagery With Self-regulation on Daily Activities in People With Parkinson's Disease
A study testing Mental imagery with self-regulation and Exercise and health education in people with Parkinson s Disease, run by The Hong Kong Polytechnic University at 1 site in Hong Kong.
Trial summary
The goal of this clinical trial is to learn whether mental imagery combined with self-regulation can improve daily activities in people with Parkinson's disease. The main questions it aims to answer are: Does mental imagery with self-regulation improve performance in daily activities? Does it improve overall… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Parkinson s Disease
- What is being tested?
- Mental imagery with self-regulation and Exercise and health education
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 120 participants
- Where
- 1 siteHong Kong
- Study dates
- 5 Oct 2026to 31 Dec 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- have been diagnosed with Parkinson's disease by a neurologist according to the diagnostic criteria of the UK Parkinson's Disease Society Brain Bank, regardless of their age range;
- have Parkinson's disease with mild-to-moderate severity determined in the 'ON' phase, with scores of 1 to 3 on the Hoehn and Yahr scale;
- have been screened for intact attention and short-term memory functions by repeating all five words in the 'memory' question and scoring '1' (full marks) in forward order repeat in the 'read list of digits' in the 'attention' question of the Montreal Cognitive Assessment; and
- do not have depression, as indicated by scores less than 2 on the 4-item Geriatric Depression Scale
Who cannot join
- severe dyskinesia or severe ON-OFF motor fluctuations;
- stereotaxic brain surgery for Parkinson's disease;
- changes in dopamine therapy dose within 3 months before the study starts;
- disabling comorbidities such as cognitive disorders including stroke and depression; and
- language difficulties, unstable cardia or reparatory illness, or other medical conditions that may affect participation.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Hong Kong1 site, 1 recruiting
- Recruiting
The Hong Kong Polytechnic University
Hong Kong
Karen P. Y. Liu, 852-27665386, karen.liu@polyu.edu.hk
About this study
The goal of this clinical trial is to learn whether mental imagery combined with self-regulation can improve daily activities in people with Parkinson's disease.
The main questions it aims to answer are:
- Does mental imagery with self-regulation improve performance in daily activities?
- Does it improve overall, cognitive, and motor function?
Researchers will compare mental imagery with self-regulation with exercise and health education to assess their effects.
Participants will:
- Complete a six-week mental imagery and self-regulation programme, conventional learning, or exercise.
- Complete assessments of daily activities and overall, cognitive, and motor function.
Read the detailed description
With less dopamine in the substantia nigra of the basal ganglia, People with Parkinson's Disease (PwPD) experience symptoms across a spectrum. This causes impairment of their supervisory attentional system (SAS), affecting the person's mental flexibility and ability to focus attention on movements and leading to a reliance on slow and energy-intensive action. As a result, PwPD have many restrictions not only in gait and walking but also in completing routine daily activities such as bathing and shopping.
Conventional rehabilitation, such as exercise, targets their motor issues and enhances mobility. However, exercise may not directly work on SAS impairment and non-motor symptoms and, therefore, may only produce short-term benefits. Cueing is another strategy that facilitates motor performance in PwPD by shifting attention resources to compensate for movement initiation and sequencing. Our previous systematic review and meta-analysis showed that cueing improved task performance in PwPD with a lasting effect from 1 week to 1 year. However, cueing relies on an external cue and device, which is unrealistic for daily and community living and specific to a particular task, such as walking. Generalisation to other daily activities is limited.
The use of Mental Imagery (MI) is a rehabilitation strategy that has been studied to improve function in PwPD. MI works under a cognitive mechanism that tackles the SAS impairment and improves the attentional focus required in learning movement strategies. However, conflicting results in the use of MI in PwPD have been found. When reviewing the intervention protocols of clinical trials with positive results, the intervention broke tasks into steps, engaged participants in self-awareness of their own problems, or drew attention toward task performance during mental imagery. Drawing attention toward task performance seems to work using a cognitive approach to tackle SAS impairment and improve the attentional focus required in learning movement strategies. Modification of MI intervention protocols by adding an extra component to enhance attentional focus when learning movement strategies and engaging them in understanding the motor demand based on their ability are hypothesised to be the key to guaranteeing the success of these MI intervention protocols. Self-regulation is a strategy that can offer this extra component.
Self-regulation has been used widely in education to enhance learning. It involves self-monitoring and self-modification of one's behaviour. In rehabilitation, self-regulation has been shown to enhance participation in daily activities in people with stroke. Using a cognitive approach, self-regulation is an active learning strategy that helps individuals to be aware of their own ability and environment and control their own learning. Self-regulation and executive function are connected theoretically and empirically. Both involve the processes of (1) organising/prioritising; (2) focusing/sustaining; (3) regulating alertness; (4) managing frustration and emotion; (5) utilising working memory and recalling; and (6) monitoring and self-regulating action. This is achieved by the person monitoring their own performance, identifying their solutions and reflecting on their success. Apart from people with stroke, the Principal Investigator and the team also demonstrated the effective use of self-regulation in autistic children in learning school and daily activities.
Our previous studies demonstrated the effective use of MI with self-regulation in improving the daily activities in people with stroke, with 1-month carry-over effects and generalisation to untrained daily activities. Our research showed that combining MI with self-regulation could improve attention and sequencing-processing abilities and monitoring of daily activity performance by self-reflecting on successful performance in people with stroke. The cognitive processes in understanding one's abilities and deficits, analysing the demands in each step of a task, and planning and imagining performing the individual task steps will allow PwPD to process all the cognitive and motor demands as well as their own abilities in coping with these task demands.
Based on our previous research on stroke, we developed a MI with self-regulation program for PwPD (MI-SeR) with feedback from two consumer co-designed workshops with five health professionals and five PwPD and their carers and pilot-tested it on 11 patients with mild to moderate PD. The MI-SeR was shown to have satisfactory feasibility (85% completed the intervention program) and excellent acceptability, with all participants who completed the program agreeing that they would recommend it to other PwPD. After the 6-week MI-SeR, there were significant improvements in patient-rated perceived daily activities and a medium effect size as measured by the Canadian Occupational Performance Measure (p = .011, effect size = .47), and attention and mental flexibility of cognitive function, also with medium effect sizes, as measured by the Trail Making A and Trail Making B, respectively (p ≤ .05, effect size = .59; p = .022, effect size = .69).
Objectives
- Primary objective To investigate the effects of MI with self-regulation (MI-SeR), compared with conventional learning and exercise (control intervention), on improving patient-rated perceived performance of daily activities in PwPD.
- Secondary objective To assess the effects of the two interventions on daily functioning, cognitive function, and motor function in PwPD.
- Exploratory objective To explore whether MI-SeR is associated with changes in fNIRS-measured cortical haemodynamic responses during ADL-related MI tasks, and whether the intervention effects on daily activity performance are mediated through improvements in prefrontal executive function quantified by fNIRS-assessed cortical activity.
- Conditions
- Parkinson s Disease
- Being tested
- Mental imagery with self-regulation, Exercise and health education
- Keywords
- Parkinson's disease, Daily activities, Early intervention, Mental imagery, Self-regulation
- Medical subject headings
- Parkinson Disease, Self-Control
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Mental imagery with self-regulationOther
Also called MI-SeR
Participants will receive a 6-week program consisting of weekly 45-minute group sessions (2-4 participants per group), mental imagery training, self-regulation strategies, home practice, and telephone follow-up. Training covers important daily activities (e.g., preparing breakfast, washing dishes, making phone calls), emphasizing task analysis, problem identification, solution development and implementation.
Exercise and health educationOther
Participants will receive a 6-week exercise and health education intervention, consisting of weekly 45-minute group sessions (2-4 participants per group), home practice, and telephone follow-up.
| Study group | Role | What they receive |
|---|---|---|
| Mental imagery with self-regulation | Experimental | Participants will receive mental imagery training, self-regulation strategies. Training covers important daily activities (e.g., preparing breakfast, washing dishes, making phone calls), emphasizing task analysis, problem identification, solution development and implementation. Receives: Other: Mental imagery with self-regulation |
| Exercise and health education | Active comparator | Participants will receive exercise, including gross and fine motor exercises, and health education. Receives: Other: Exercise and health education |
What is being measured
The primary outcome is the main question the study is designed to answer.
Canadian Occupational Performance Measure
The Canadian Occupational Performance Measure is a standardised client-centred outcome measure that assesses an individual's performance in daily activities (Law et al., 2005). This sensitive instrument focuses on participants' perceptions of their functioning and improvements in daily activities.
Measured: Pre-intervention, at the end of the 6-week intervention, and at 3 and 6 months after intervention completion
Secondary outcomes (7)
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale
The Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale assesses the non-motor and motor experiences of daily living and motor complications in People with Parkinson's Disease.
Measured: Pre-intervention, at the end of the 6-week intervention, and at 3 and 6 months after intervention completion
Kinesthetic and Visual Imagery Questionnaire-10
The Kinesthetic and Visual Imagery Questionnaire-10 will be used to assess motor imagery ability. It evaluates two dimensions of motor imagery: the clarity of visual imagery and the intensity of kinesthetic sensations associated with imagined movements. Participants first physically perform each movement and then imagine performing the same movement from a first-person perspective.
Measured: Pre-intervention, at the end of the 6-week intervention, and at 3 and 6 months after intervention completion
Color Trails Test
The Color Trails Test assesses a person's executive functioning and is considered a sensitive test for detecting different types of brain damage in PwPD (D'Elia et al., 1989). CTT1 evaluates a person's visual scanning, sequencing, and processing speed; and CTT2 adds an alternating sequence component and is sensitive to executive functions such as mental flexibility and divided attention.
Measured: Pre-intervention, at the end of the 6-week intervention, and at 3 and 6 months after intervention completion
Stroop Color and Word Test
The Stroop Color and Word Test assesses a person's mental flexibility - the ability to inhibit an automatic response and to establish and maintain a new, nonhabitual response based on environmental constraints.
Measured: Pre-intervention, at the end of the 6-week intervention, and at 3 and 6 months after intervention completion
Timed Up and Go test
The Timed Up and Go test is a standardised test that records the time taken by an individual to stand up from an armchair, walk 3 metres, turn and walk back at their usual speed, and sit on the chair again.
Measured: Pre-intervention, at the end of the 6-week intervention, and at 3 and 6 months after intervention completion
10-Meter Walk Test
The 10-Meter Walk Test is recommended to measure gait speed in people with Parkinson's disease and is proven to be a reliable and valid measure. Gait speed is measured in metres per second over the middle 6 metres.
Measured: Pre-intervention, at the end of the 6-week intervention, and at 3 and 6 months after intervention completion
European Quality of Life, Five Dimensions, Five Levels
The European Quality of Life, Five Dimensions, Five Levels instrument assesses five domains: mobility, self-care, usual activity, pain, and anxiety. Participants are asked to rate their self-perceived level of the five domains on a five-level scale of severity.
Measured: Pre-intervention, at the end of the 6-week intervention, and at 3 and 6 months after intervention completion
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Oct 2026
- Study start5 Oct 2026 (estimated)
- Primary completion31 Dec 2027 (estimated)
- Study completion31 Dec 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Parkinson s DiseaseStudies of the same condition, open and under way.
- More trials run by The Hong Kong Polytechnic UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 120 participants (estimated)
Sponsor and investigators
- Lead sponsor
- The Hong Kong Polytechnic University
- Sponsor type
- University, hospital or other
- Collaborators
- Tung Wah Hospital, The University of Hong Kong-Shenzhen Hospital
- Responsible party
- Principal investigator, LIU Karen, The Hong Kong Polytechnic University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07860294
- Sponsor's protocol ID
- Hongkongpu_MI_SeR for PD
- Acronym
- MI-SeR
- Status last verified
- Sep 2026
- First submitted
- 30 Sep 2026
- Last updated
- 6 Oct 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Because of data privacy, IPD will not be shared.
Study at a glance
From the registry record, last updated by the sponsor on 6 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Mental Imagery With Self-regulation on Daily Activities in People With Parkinson's Disease
- ClinicalTrials.gov ID
- NCT07860294
- Acronym / sponsor ID
- MI-SeR / Hongkongpu_MI_SeR for PD
- Conditions
- Parkinson s Disease
- Keywords
- Parkinson's disease, Daily activities, Early intervention, Mental imagery, Self-regulation
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 120 participants (estimated)
- Lead sponsor
- The Hong Kong Polytechnic UniversityUniversity, hospital or other
- Collaborators
- Tung Wah Hospital, The University of Hong Kong-Shenzhen Hospital
- Study start
- 5 Oct 2026 (estimated)
- Primary completion
- 31 Dec 2027 (estimated)
- Study completion
- 31 Dec 2028 (estimated)
- First posted
- 6 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to learn whether mental imagery combined with self-regulation can improve daily activities in people with Parkinson's disease.
The main questions it aims to answer are:
- Does mental imagery with self-regulation improve performance in daily activities?
- Does it improve overall, cognitive, and motor function?
Researchers will compare mental imagery with self-regulation with exercise and health education to assess their effects.
Participants will:
- Complete a six-week mental imagery and self-regulation programme, conventional learning, or exercise.
- Complete assessments of daily activities and overall, cognitive, and motor function.
Detailed description
With less dopamine in the substantia nigra of the basal ganglia, People with Parkinson's Disease (PwPD) experience symptoms across a spectrum. This causes impairment of their supervisory attentional system (SAS), affecting the person's mental flexibility and ability to focus attention on movements and leading to a reliance on slow and energy-intensive action. As a result, PwPD have many restrictions not only in gait and walking but also in completing routine daily activities such as bathing and shopping.
Conventional rehabilitation, such as exercise, targets their motor issues and enhances mobility. However, exercise may not directly work on SAS impairment and non-motor symptoms and, therefore, may only produce short-term benefits. Cueing is another strategy that facilitates motor performance in PwPD by shifting attention resources to compensate for movement initiation and sequencing. Our previous systematic review and meta-analysis showed that cueing improved task performance in PwPD with a lasting effect from 1 week to 1 year. However, cueing relies on an external cue and device, which is unrealistic for daily and community living and specific to a particular task, such as walking. Generalisation to other daily activities is limited.
The use of Mental Imagery (MI) is a rehabilitation strategy that has been studied to improve function in PwPD. MI works under a cognitive mechanism that tackles the SAS impairment and improves the attentional focus required in learning movement strategies. However, conflicting results in the use of MI in PwPD have been found. When reviewing the intervention protocols of clinical trials with positive results, the intervention broke tasks into steps, engaged participants in self-awareness of their own problems, or drew attention toward task performance during mental imagery. Drawing attention toward task performance seems to work using a cognitive approach to tackle SAS impairment and improve the attentional focus required in learning movement strategies. Modification of MI intervention protocols by adding an extra component to enhance attentional focus when learning movement strategies and engaging them in understanding the motor demand based on their ability are hypothesised to be the key to guaranteeing the success of these MI intervention protocols. Self-regulation is a strategy that can offer this extra component.
Self-regulation has been used widely in education to enhance learning. It involves self-monitoring and self-modification of one's behaviour. In rehabilitation, self-regulation has been shown to enhance participation in daily activities in people with stroke. Using a cognitive approach, self-regulation is an active learning strategy that helps individuals to be aware of their own ability and environment and control their own learning. Self-regulation and executive function are connected theoretically and empirically. Both involve the processes of (1) organising/prioritising; (2) focusing/sustaining; (3) regulating alertness; (4) managing frustration and emotion; (5) utilising working memory and recalling; and (6) monitoring and self-regulating action. This is achieved by the person monitoring their own performance, identifying their solutions and reflecting on their success. Apart from people with stroke, the Principal Investigator and the team also demonstrated the effective use of self-regulation in autistic children in learning school and daily activities.
Our previous studies demonstrated the effective use of MI with self-regulation in improving the daily activities in people with stroke, with 1-month carry-over effects and generalisation to untrained daily activities. Our research showed that combining MI with self-regulation could improve attention and sequencing-processing abilities and monitoring of daily activity performance by self-reflecting on successful performance in people with stroke. The cognitive processes in understanding one's abilities and deficits, analysing the demands in each step of a task, and planning and imagining performing the individual task steps will allow PwPD to process all the cognitive and motor demands as well as their own abilities in coping with these task demands.
Based on our previous research on stroke, we developed a MI with self-regulation program for PwPD (MI-SeR) with feedback from two consumer co-designed workshops with five health professionals and five PwPD and their carers and pilot-tested it on 11 patients with mild to moderate PD. The MI-SeR was shown to have satisfactory feasibility (85% completed the intervention program) and excellent acceptability, with all participants who completed the program agreeing that they would recommend it to other PwPD. After the 6-week MI-SeR, there were significant improvements in patient-rated perceived daily activities and a medium effect size as measured by the Canadian Occupational Performance Measure (p = .011, effect size = .47), and attention and mental flexibility of cognitive function, also with medium effect sizes, as measured by the Trail Making A and Trail Making B, respectively (p ≤ .05, effect size = .59; p = .022, effect size = .69).
Objectives
- Primary objective To investigate the effects of MI with self-regulation (MI-SeR), compared with conventional learning and exercise (control intervention), on improving patient-rated perceived performance of daily activities in PwPD.
- Secondary objective To assess the effects of the two interventions on daily functioning, cognitive function, and motor function in PwPD.
- Exploratory objective To explore whether MI-SeR is associated with changes in fNIRS-measured cortical haemodynamic responses during ADL-related MI tasks, and whether the intervention effects on daily activity performance are mediated through improvements in prefrontal executive function quantified by fNIRS-assessed cortical activity.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Mental imagery with self-regulation | Experimental | Other: Mental imagery with self-regulationParticipants will receive mental imagery training, self-regulation strategies. Training covers important daily activities (e.g., preparing breakfast, washing dishes, making phone calls), emphasizing task analysis, problem identification, solution development and implementation. |
| Exercise and health education | Active comparator | Other: Exercise and health educationParticipants will receive exercise, including gross and fine motor exercises, and health education. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- have been diagnosed with Parkinson's disease by a neurologist according to the diagnostic criteria of the UK Parkinson's Disease Society Brain Bank, regardless of their age range;
- have Parkinson's disease with mild-to-moderate severity determined in the 'ON' phase, with scores of 1 to 3 on the Hoehn and Yahr scale;
- have been screened for intact attention and short-term memory functions by repeating all five words in the 'memory' question and scoring '1' (full marks) in forward order repeat in the 'read list of digits' in the 'attention' question of the Montreal Cognitive Assessment; and
- do not have depression, as indicated by scores less than 2 on the 4-item Geriatric Depression Scale
Key exclusion criteria (5 listed)
- severe dyskinesia or severe ON-OFF motor fluctuations;
- stereotaxic brain surgery for Parkinson's disease;
- changes in dopamine therapy dose within 3 months before the study starts;
- disabling comorbidities such as cognitive disorders including stroke and depression; and
- language difficulties, unstable cardia or reparatory illness, or other medical conditions that may affect participation.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Mental imagery with self-regulationAlso: MI-SeRParticipants will receive a 6-week program consisting of weekly 45-minute group sessions (2-4 participants per group), mental imagery training, self-regulation strategies, home practice, and telephone follow-up. Training covers important daily activities (e.g., preparing breakfast, washing dishes, making phone calls), emphasizing task analysis, problem identification, solution development and implementation. | Other | Mental imagery with self-regulation |
| Exercise and health educationParticipants will receive a 6-week exercise and health education intervention, consisting of weekly 45-minute group sessions (2-4 participants per group), home practice, and telephone follow-up. | Other | Exercise and health education |
Primary outcome
Canadian Occupational Performance Measure
Time frame: Pre-intervention, at the end of the 6-week intervention, and at 3 and 6 months after intervention completion
The Canadian Occupational Performance Measure is a standardised client-centred outcome measure that assesses an individual's performance in daily activities (Law et al., 2005). This sensitive instrument focuses on participants' perceptions of their functioning and improvements in daily activities.
7 secondary outcomes
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale
Time frame: Pre-intervention, at the end of the 6-week intervention, and at 3 and 6 months after intervention completion
Kinesthetic and Visual Imagery Questionnaire-10
Time frame: Pre-intervention, at the end of the 6-week intervention, and at 3 and 6 months after intervention completion
Color Trails Test
Time frame: Pre-intervention, at the end of the 6-week intervention, and at 3 and 6 months after intervention completion
Stroop Color and Word Test
Time frame: Pre-intervention, at the end of the 6-week intervention, and at 3 and 6 months after intervention completion
Timed Up and Go test
Time frame: Pre-intervention, at the end of the 6-week intervention, and at 3 and 6 months after intervention completion
10-Meter Walk Test
Time frame: Pre-intervention, at the end of the 6-week intervention, and at 3 and 6 months after intervention completion
European Quality of Life, Five Dimensions, Five Levels
Time frame: Pre-intervention, at the end of the 6-week intervention, and at 3 and 6 months after intervention completion
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Oct 2026.
- Individual participant dataSharing planned: No. Because of data privacy, IPD will not be shared.
Related trials for Parkinson s Disease
Enrolling by invitationObservational study
Early Molecular Biomarkers for Differentiating Parkinsonian Syndromes
PARKINSON DISEASE (Disorder), Atypical Parkinsonism
Active, not recruitingPhase 1/2
Clinical Safety and Efficacy of Umbilical Cord Mesenchymal Stromal Cells-derived Exosomes in Patients With Parkinson's Disease
Parkinson Disease (PD)
Active, not recruitingObservational study
Adaptive DBS to Offset STN Dysregulation During Exercise in PD
Parkinson Disease
Not yet recruiting
Compulsive Eating and Brain's Reward System in Different Pathologies
PARKINSON DISEASE (Disorder), Bipolar 1 Disorder
Not yet recruiting
Evaluating the Effect of the Zeen Mobility Device on Clinical Practicality, Safety, and Impact (Via Assessments of Walking, Standing Tolerance, Balance, Endurance, Effort, and Participation in Daily Tasks) in an Outpatient Rehabilitation Setting for Individuals With Mobility Impairments.
Stroke, Parkinson's Disease (PD)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Mental imagery with self-regulation and Exercise and health education in people with Parkinson s Disease, run by The Hong Kong Polytechnic University at 1 site in Hong Kong.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 6 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Karen P. Y. Liu (852 27665386, karen.liu@polyu.edu.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Canadian Occupational Performance Measure (time frame: Pre-intervention, at the end of the 6-week intervention, and at 3 and 6 months after intervention completion). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Oct 2026.